New blood pressure cuff aims to replace needles
NCT ID NCT07628296
First seen Jun 10, 2026 · Last updated Jun 20, 2026 · Updated 3 times
Summary
This study tests a new non-invasive blood pressure device that uses a cuff on the arm or thigh, comparing its readings to those from an arterial line (a tube in an artery). Fifteen adults who already have an arterial line as part of their care will participate. The goal is to see if the cuff can measure blood pressure as accurately as the invasive method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tampere Heart Hospital
RECRUITINGTampere, 33521, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to more accurate non-invasive blood pressure monitors, reducing the need for invasive arterial lines.
What could go wrong
This is a very small, early-stage study with only 15 participants, so results may not apply to everyone. The device may not prove accurate enough for widespread use.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.